Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster.

Swiss pharma Roche is staying in lockstep with Eli Lilly, expanding its artificial intelligence offerings and Nvidia partnership shortly after the latter drugmaker unveiled an Nvidia supercomputer. Roche’s “hybrid-cloud AI factory” is designed to accelerate development for new therapeutics and diagnostics,

KX, a global leader in real-time, time-series, and AI-driven analytics, today announced general availability of two capital markets agentic AI blueprints developed in collaboration with NVIDIA: an AI Research Assistant and Trading Signal Agents.

NVIDIA, a leader in AI computing technologies, announced a strategic partnership with Adobe at NVIDIA GTC 2026, the world’s largest AI and accelerated computing conference, held in San Jose, California.

Nvidia, the computer chip giant, continues its deep dive into expanding artificial intelligence technology in the medtech and cancer research arenas, this time with diagnostics maker Droplet Biosciences.

As an industry, healthcare tends to be slow-moving and significantly behind others. There are many reasons for this, including budgets, availability of technology and the fact that any errors in healthcare can result in lost lives.

The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new species across thousands of sites globally.By partnering with Anthropic, Ultima Genomics,

The move could position the AI infrastructure powerhouse to quickly compete with OpenAI, Anthropic, and DeepSeek.